Expertise in
1
conditions

Katrien A. De Jaeger

Eindhoven, NB, NL 
Expertise in
1
conditions
Eindhoven, NB, NL 

Overview

Katrien De Jaeger practices practicing medicine in Eindhoven, Netherlands.

Ms. De Jaeger is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Brain Tumor.

She is actively involved in clinical research, co-authoring 21 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

Eindhoven, NB, Netherlands
Other Locations
Dr Molewaterplein 40, Rotterdam, ZH 3015GD, Netherlands

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

NVALT 28/ PRL01 Durvalumab and Low-dose Prophylactic Cranial Irradiation (PCI) Versus Durvalumab and Observation in Radically Treated Patients With Stage III Non-small Cell Lung Cancer: A Phase III Randomized Study
NVALT 28/ PRL01 Durvalumab and Low-dose Prophylactic Cranial Irradiation (PCI) Versus Durvalumab and Observation in Radically Treated Patients With Stage III Non-small Cell Lung Cancer: A Phase III Randomized Study
Enrollment Status: Active_not_recruiting
Publish Date: January 29, 2025
Intervention Type: Drug, Radiation
Study Drug: Durvalumab
Study Phase: Phase 3
Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance in SCLC a Randomized Phase III Trial
Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance in SCLC a Randomized Phase III Trial
Enrollment Status: Completed
Publish Date: January 21, 2022
Intervention Type: Radiation
Study Phase: Phase 3
View 1 Less Clinical Trial

21 Total Publications

Dose-escalated twice daily radiotherapy for limited stage small cell lung cancer: an implementation strategy in the Netherlands.
Dose-escalated twice daily radiotherapy for limited stage small cell lung cancer: an implementation strategy in the Netherlands.
Journal: Journal of thoracic disease
Published: April 30, 2026

Frequently Asked Questions about Katrien A. De Jaeger

Is Katrien A. De Jaeger a top-rated expert for Small Cell Lung Cancer (SCLC)?

MediFind is an objective health platform that identifies experts based on real-world data. Katrien A. De Jaeger is classified as an Advanced expert for Small Cell Lung Cancer (SCLC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Katrien A. De Jaeger participate in research or clinical trials?

Yes. Katrien A. De Jaeger has published 21 articles and abstracts on conditions like Small Cell Lung Cancer (SCLC). You can view a list of Katrien A. De Jaeger's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. De Jaeger's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile